Literature DB >> 16772544

Liver disease and osteoporosis.

Antonio J Sanchez1, Jaime Aranda-Michel.   

Abstract

Metabolic bone disease (osteodystrophy) is an important complication of patients with chronic liver disease; its etiology is complex and multifactorial. Osteodystrophy is manifested as osteopenia/osteoporosis. Osteoporosis can predispose patients to bone fractures, increasing morbidity and mortality, especially after liver transplantation. Early evaluation, screening, and treatment of bone disorders in patients with liver disease are essential to minimize fracture risk and to improve clinical outcome and quality of life.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772544     DOI: 10.1177/0115426506021003273

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  12 in total

Review 1.  Bone health and vitamin D status in alcoholic liver disease.

Authors:  M Kizilgul; O Ozcelik; T Delibasi
Journal:  Indian J Gastroenterol       Date:  2016-06-01

2.  Hepatic osteodystrophy: An important matter for consideration in chronic liver disease.

Authors:  Germán López-Larramona; Alfredo J Lucendo; Sonia González-Castillo; José M Tenias
Journal:  World J Hepatol       Date:  2011-12-27

Review 3.  Osteodystrophy in chronic liver diseases.

Authors:  Pasquale Mansueto; Antonio Carroccio; Aurelio Seidita; Gaetana Di Fede; Antonio Craxì
Journal:  Intern Emerg Med       Date:  2012-01-13       Impact factor: 3.397

Review 4.  Chronic liver inflammation: clinical implications beyond alcoholic liver disease.

Authors:  Byoung-Jin Park; Yong-Jae Lee; Hye-Ree Lee
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

5.  Change in bone mineral density and tooth loss in Japanese community-dwelling postmenopausal women: a 5-year cohort study.

Authors:  Masanori Iwasaki; Kazutoshi Nakamura; Akihiro Yoshihara; Hideo Miyazaki
Journal:  J Bone Miner Metab       Date:  2011-11-23       Impact factor: 2.626

6.  Disturbances of parathyroid hormone-vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study.

Authors:  Arash Miroliaee; Mohsen Nasiri-Toosi; Omid Khalilzadeh; Alireza Esteghamati; Alireza Abdollahi; Mehdi Mazloumi
Journal:  Hepatol Int       Date:  2010-07-25       Impact factor: 6.047

7.  Study of Hepatic Osteodystrophy in Patients with Chronic Liver Disease.

Authors:  Yogesh Karoli; Ritu Karoli; Jalees Fatima; Mohammad Manhar
Journal:  J Clin Diagn Res       Date:  2016-08-01

8.  Pelvic bone fractures mimicking bone metastases in a patient with hepatitis B virus-associated liver cirrhosis and hepatocellular carcinoma.

Authors:  Dong Hyeon Lee; Eun Sun Jang; Hong Sang Oh; Kwang Hyun Chung; Eun Hyo Jin; Eu Jeong Ku; Eun Roh
Journal:  Korean J Intern Med       Date:  2012-11-27       Impact factor: 2.884

9.  Protective Role of Black Tea Extract against Nonalcoholic Steatohepatitis-Induced Skeletal Dysfunction.

Authors:  Subhra Karmakar; Sangita Majumdar; Anasuya Maiti; Monalisa Choudhury; Aniruddha Ghosh; Asankur S Das; Chandan Mitra
Journal:  J Osteoporos       Date:  2011-06-23

10.  Bone mineral density and secondary hyperparathyroidism in pulmonary hypertension.

Authors:  Silvia Ulrich; Martin Hersberger; Manuel Fischler; Lars C Huber; Oliver Senn; Ursula Treder; Rudolf Speich; Christoph Schmid
Journal:  Open Respir Med J       Date:  2009-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.